新华制药2024年营收创新高但利润下滑

DoNews
31 Mar

3月30日,新华制药发布2024年年报显示,公司实现营业收入84.66亿元,同比增长4.51%,创下历史新高。然而,归属于上市公司股东的净利润为4.7亿元,同比下降5.33%,归母净利润出现自2013年以来的首次下滑。扣除非经常性损益后的净利润为4.48亿元,同比减少2.93%。在研发投入方面,2024年新华制药研发费用为4.13亿元,较上年微降1.44%,研发人员数量也有所减少。值得注意的是,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10